Phospho-PLCG 2 (Tyr759) Antibody (Rabbit mAb) [N11A6]

Catalog No.: F8632

Print

Biological Description

Specificity Phospho-PLCG 2 (Tyr759) Antibody (Rabbit mAb) [N11A6] detects endogenous levels of total PLCG 2 protein only when it is phosphorylated at Tyr759.
Background PLCγ2 belongs to the phosphoinositide-specific phospholipase C gamma family and functions as the central lipase effector downstream of B-cell receptor engagement, hydrolyzing phosphatidylinositol 4,5-bisphosphate to generate the second messengers inositol trisphosphate and diacylglycerol once activated. Antigen engagement of the B-cell receptor triggers assembly of a multiprotein signalosome built from the kinases Lyn, Syk, and Btk together with the adaptor protein BLNK, and this complex directs sequential tyrosine phosphorylation of PLCγ2 at three defined sites, Tyr753, Tyr759, and Tyr1217, with the extent of Tyr1217 phosphorylation reaching roughly three times that of either Tyr753 or Tyr759 following maximal receptor stimulation. Src-family kinase inhibition and Syk depletion both abolish PLCγ2 phosphorylation across all three sites, while direct biochemical comparison of the two candidate PLCγ2 kinases shows that purified Btk phosphorylates recombinant PLCγ2 substantially more efficiently than Syk does in vitro, with Syk's principal contribution instead being phosphorylation of BLNK, which then provides the docking sites that recruit PLCγ2 into the signalosome rather than phosphorylating PLCγ2 directly. Functional reconstitution in PLCγ2-deficient DT40 B cells demonstrates that Tyr753 and Tyr759 specifically are required for PLCγ2 to restore calcium signaling downstream of B-cell receptor engagement, and combined mutation of both residues, Y753F/Y759F, eliminates detectable PLCγ2 tyrosine phosphorylation in stimulated cells entirely, establishing these two sites as functionally essential for productive signaling rather than incidental phosphorylation events. Consistent with this, across primary measurements the extent of phosphorylation at Tyr753 and Tyr759 correlates directly with PLCγ2 lipase activity, while phosphorylation at Tyr1217 does not show this correlation, distinguishing Tyr759 as a functionally activating phosphorylation site rather than merely a marker of receptor engagement. Membrane-raft-targeting experiments using a constitutively membrane-anchored PLCγ2 construct confirm that Tyr753 and Tyr759 are specifically required for substrate hydrolysis following stimulation, a requirement that persists even when the normal BLNK-dependent recruitment step is bypassed, while PLCγ2's own SH2 domains contribute comparatively little to this transient activation step and instead appear to stabilize the activated enzyme during sustained signaling. Immunoreceptor engagement in T cells and platelets similarly induces phosphorylation at Tyr753 and Tyr759 but not Tyr1217, indicating this activating phosphorylation mechanism operates across multiple immune cell lineages rather than being restricted to B cells, and disruption of Tyr759-dependent PLCγ2 activation is relevant to immune dysregulation phenotypes and to PLCG2 mutations associated with resistance to Btk-targeted therapy in chronic lymphocytic leukemia.

Usage Information

Application WB, IF Dilution
WB IF
1:500-1:1000 1:50 - 1:100
Reactivity Human
Source Rabbit Monoclonal Antibody MW 148 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)		 -20°C (avoid freeze-thaw cycles), 2 years

References

  • https://pubmed.ncbi.nlm.nih.gov/11606584/
  • https://pubmed.ncbi.nlm.nih.gov/15509800/

Application Data